Apnea of Prematurity and Caffeine Pharmacokinetics: Potential Impact on Hospital Discharge

Overview

Journal J Perinatol

Specialty Gynecology & Obstetrics

Date 2015 Nov 13

PMID 26562367

Citations 20

Authors

J Doyle

D Davidson

S Katz

M Varela

D Demeglio

J DeCristofaro

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the half-life of serum caffeine concentrations and its relation to apnea of prematurity (AOP) after caffeine is discontinued in preparation for hospital discharge.

Study Design: Prospective cohort study involving preterm infants with gestational ages ⩽33 weeks at birth. After caffeine was discontinued, serum caffeine concentrations and electronic detection of pathologic apnea, defined a priori, were obtained at 24 and 168 h, respectively.

Result: Caffeine levels decreased from 13.3±3.8 to 4.3±2 mg l(-1) (n=50, mean±s.d.) at 24 and 168 h, respectively (P<0.01). The mean caffeine half-life was 87±25 h at 35±1 weeks postmenstrual age. Seven days after discontinuation of caffeine, 64% of the infants had pathologic apnea.

Conclusion: Hospital discharge planning for preterm infants with a history of AOP should be carefully considered after discontinuing caffeine. This study showed that caffeine may not reach subtherapeutic levels until around 11-12 days.

Citing Articles

Strategies for cessation of caffeine administration in preterm infants.

Urru S, Geist M, Carlinger R, Bodrero E, Bruschettini M Cochrane Database Syst Rev. 2024; 7:CD015802.

PMID: 39045901 PMC: 11267609. DOI: 10.1002/14651858.CD015802.pub2.

Predictors for poor daily weight gain in preterm neonates exposed to different dose regimens of caffeine in ICU- a retrospective cohort study.

Ahmed S, Rehman A, Bibi Z, Iftikhar S, Raza M, Yousuf H BMC Pediatr. 2024; 24(1):401.

PMID: 38898410 PMC: 11188204. DOI: 10.1186/s12887-024-04850-8.

Association of Caffeine Daily Dose With Respiratory Outcomes in Preterm Neonates: A Retrospective Cohort Study.

Rauf S, Shah S, Bibi Z, Munir R, Jiskani H, Ahmad S Inquiry. 2024; 61:469580241248098.

PMID: 38666733 PMC: 11055476. DOI: 10.1177/00469580241248098.

Dose-Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates-A Retrospective Cohort Study.

Hussain I, Kumar M, Ali A, Naz F, Khan W, Salat M Dose Response. 2024; 22(2):15593258241247185.

PMID: 38617389 PMC: 11016235. DOI: 10.1177/15593258241247185.

Longitudinal pilot study of oxygen saturation indices in healthy preterm infants.

Falconer O, Ivy S, Le Carpentier D, Gavlak J, Liddle N, Senior E Pediatr Res. 2023; 94(6):2062-2069.

PMID: 37542167 PMC: 10665185. DOI: 10.1038/s41390-023-02741-9.

References

Darnall R, Kattwinkel J, Nattie C, Robinson M . Margin of safety for discharge after apnea in preterm infants. Pediatrics. 1997; 100(5):795-801. DOI: 10.1542/peds.100.5.795. View

Davis P, Schmidt B, Roberts R, Doyle L, Asztalos E, Haslam R . Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups. J Pediatr. 2009; 156(3):382-7. DOI: 10.1016/j.jpeds.2009.09.069. View

Aranda J, Beharry K, Valencia G, Natarajan G, Davis J . Caffeine impact on neonatal morbidities. J Matern Fetal Neonatal Med. 2010; 23 Suppl 3:20-3. DOI: 10.3109/14767058.2010.517704. View

Charles B, Townsend S, Steer P, Flenady V, Gray P, Shearman A . Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. Ther Drug Monit. 2008; 30(6):709-16. DOI: 10.1097/FTD.0b013e3181898b6f. View

Leon A, Michienzi K, Ma C, Hutchison A . Serum caffeine concentrations in preterm neonates. Am J Perinatol. 2006; 24(1):39-47. DOI: 10.1055/s-2006-958163. View

Comer A, Perry C, Figgitt D . Caffeine citrate: a review of its use in apnoea of prematurity. Paediatr Drugs. 2001; 3(1):61-79. DOI: 10.2165/00128072-200103010-00005. View

Merritt T, Pillers D, Prows S . Early NICU discharge of very low birth weight infants: a critical review and analysis. Semin Neonatol. 2004; 8(2):95-115. DOI: 10.1016/S1084-2756(02)00219-1. View

Alur P, Bollampalli V, Bell T, Hussain N, Liss J . Serum caffeine concentrations and short-term outcomes in premature infants of ⩽29 weeks of gestation. J Perinatol. 2014; 35(6):434-8. DOI: 10.1038/jp.2014.226. View

Subhani M, Katz S, DeCristofaro J . Prediction of postdischarge complications by predischarge event recordings in infants with apnea of prematurity. J Perinatol. 2000; 20(2):92-5. DOI: 10.1038/sj.jp.7200320. View

10.

Ho T, Dukhovny D, Zupancic J, Goldmann D, Horbar J, Pursley D . Choosing Wisely in Newborn Medicine: Five Opportunities to Increase Value. Pediatrics. 2015; 136(2):e482-9. PMC: 9923615. DOI: 10.1542/peds.2015-0737. View

11.

Eichenwald E, Aina A, Stark A . Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics. 1997; 100(3 Pt 1):354-9. DOI: 10.1542/peds.100.3.354. View

12.

Amin S, Burnell E . Monitoring apnea of prematurity: validity of nursing documentation and bedside cardiorespiratory monitor. Am J Perinatol. 2012; 30(8):643-8. PMC: 4285412. DOI: 10.1055/s-0032-1329694. View

13.

Schmidt B, Roberts R, Davis P, Doyle L, Barrington K, Ohlsson A . Caffeine therapy for apnea of prematurity. N Engl J Med. 2006; 354(20):2112-21. DOI: 10.1056/NEJMoa054065. View

14.

Lodha A, Seshia M, McMillan D, Barrington K, Yang J, Lee S . Association of early caffeine administration and neonatal outcomes in very preterm neonates. JAMA Pediatr. 2014; 169(1):33-8. DOI: 10.1001/jamapediatrics.2014.2223. View

15.

Di Fiore J, Arko M, Miller M, Krauss A, Betkerur A, Zadell A . Cardiorespiratory events in preterm infants referred for apnea monitoring studies. Pediatrics. 2001; 108(6):1304-8. DOI: 10.1542/peds.108.6.1304. View

16.

Aldridge A, Aranda J, NEIMS A . Caffeine metabolism in the newborn. Clin Pharmacol Ther. 1979; 25(4):447-53. DOI: 10.1002/cpt1979254447. View

17.

Le Guennec J, Billon B, Pare C . Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease, and breast-feeding. Pediatrics. 1985; 76(5):834-40. View

18.

Haddad W, Haddad W, Sajous C, Hummel P, Guo R . Discontinuing caffeine in preterm infants at 33-35 weeks corrected gestational age: Failure rate and predictive factors. J Neonatal Perinatal Med. 2015; 8(1):41-45. DOI: 10.3233/NPM-15814071. View

19.

Natarajan G, Botica M, Thomas R, Aranda J . Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise?. Pediatrics. 2007; 119(5):936-40. DOI: 10.1542/peds.2006-2986. View

20.

Ramanathan R, Corwin M, Hunt C, Lister G, Tinsley L, Baird T . Cardiorespiratory events recorded on home monitors: Comparison of healthy infants with those at increased risk for SIDS. JAMA. 2001; 285(17):2199-207. DOI: 10.1001/jama.285.17.2199. View